Michele Reni
Vita-Salute San Raffaele University(IT)San Raffaele University of Rome(IT)Mylan (South Africa)(ZA)IRCCS Ospedale San Raffaele(IT)Istituti di Ricovero e Cura a Carattere Scientifico(IT)Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Glioma Diagnosis and Treatment, Neuroendocrine Tumor Research Advances, Renal cell carcinoma treatment
Most-Cited Works
- → Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine(2013)6,561 cited
- → Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer(2019)2,145 cited
- → Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience(2003)830 cited
- → Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer(2011)687 cited
- → High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial(2009)659 cited
- → Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial